BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30881899)

  • 1. Personalising medicine in inflammatory bowel disease-current and future perspectives.
    Ashton JJ; Mossotto E; Ennis S; Beattie RM
    Transl Pediatr; 2019 Jan; 8(1):56-69. PubMed ID: 30881899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine in inflammatory bowel disease: concept, progress and challenges.
    Borg-Bartolo SP; Boyapati RK; Satsangi J; Kalla R
    F1000Res; 2020; 9():. PubMed ID: 32047622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical therapy of inflammatory bowel disease for the 21st century.
    Robinson M
    Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the management of growth failure in childhood inflammatory bowel disease.
    Heuschkel R; Salvestrini C; Beattie RM; Hildebrand H; Walters T; Griffiths A
    Inflamm Bowel Dis; 2008 Jun; 14(6):839-49. PubMed ID: 18266237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
    Verstockt B; Noor NM; Marigorta UM; Pavlidis P; Deepak P; Ungaro RC;
    J Crohns Colitis; 2021 Sep; 15(9):1431-1442. PubMed ID: 33730756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems in diagnosis of IBD in children.
    Büller HA
    Neth J Med; 1997 Feb; 50(2):S8-11. PubMed ID: 9050326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
    Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
    Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting and preventing complications in children with inflammatory bowel disease.
    Grover Z
    Transl Pediatr; 2019 Jan; 8(1):70-76. PubMed ID: 30881900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease Prognostic Biomarkers in Inflammatory Bowel Diseases-A Reality Check.
    Zilbauer M; Heuschkel R
    J Crohns Colitis; 2022 Jan; 16(1):162-165. PubMed ID: 34240137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can molecular stratification improve the treatment of inflammatory bowel disease?
    Wang C; Baer HM; Gaya DR; Nibbs RJB; Milling S
    Pharmacol Res; 2019 Oct; 148():104442. PubMed ID: 31491469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future directions in inflammatory bowel disease management.
    D'Haens GR; Sartor RB; Silverberg MS; Petersson J; Rutgeerts P
    J Crohns Colitis; 2014 Aug; 8(8):726-34. PubMed ID: 24742736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating children with inflammatory bowel disease: Current and new perspectives.
    Guariso G; Gasparetto M
    World J Gastroenterol; 2017 Aug; 23(30):5469-5485. PubMed ID: 28852307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic modelling in IBD.
    Rimmer P; Iqbal T
    Best Pract Res Clin Gastroenterol; 2023 Dec; 67():101877. PubMed ID: 38103929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA; Malekzadeh R; Keshavarzian A
    Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.